タンパク質半合成戦略を用いてC端末の翻訳後の改変の役割を明らかにする:チロシン125におけるα-シヌクレインのリン酸化
Mirva Hejjaoui1, Sara Butterfield, Bruno Fauvet
1Laboratory of Molecular and Chemical Biology of Neurodegeneration, Brain Mind Institute, Ecole Polytechnique Fédérale de Lausanne (EPFL), CH-1015 Lausanne, Switzerland.
Journal of the American Chemical Society
|February 21, 2012
まとめ
研究者らは,翻訳後の修正 (PTMs) でアルファ-シヌクレイン (α-syn) を正確に修正する新しい方法を開発しました. これにより,リン酸化のような特定のPTMが,α-synの集積と疾患における機能にどのように影響するか研究することができます.
科学分野:
- バイオケミストリー バイオケミストリー
- 神経科学は神経科学である.
- 分子生物学は分子生物学である.
背景:
- 翻訳後の改変 (PTMs) はアルファ-シヌクレイン (α-syn) 集積と毒性に影響するが,その特定の役割と規制は不明である.
- 既存の方法では,PTM,特にフォスフォチロシンを導入するためのサイト固有の制御が欠如しており,機能的研究を妨げています.
- 選択的α-シンリン酸化のためのキナーゼを特定することは,極めて重要ですが,困難です.
研究 の 目的:
- α-syn.でPTMのサイト固有の導入のための汎用性のある半合成戦略を開発する.
- 均質で,C端末で改変されたα-synの変種をミリグラムの量で作る.
- 選択的Y125リン酸化がα-syn構造,集積,膜結合,および局所化に及ぼす影響を調査する.
主な方法:
- 一般的で効率的な半合成戦略を開発しました.
- シングルまたは複数のPTMのサイト固有の導入を有効にしました.
- ホモゲンなC端末改変α-synをミリグラム単位で準備した.
主要な成果:
- Y125での選択的リン酸化を含むPTMをα-syn.に成功裏に導入しました.
- サイト固有のY125リン酸化の影響に関する最初の調査を可能にしました.
- 詳細な構造的および機能的分析のために,均質なα-syn変種を提供した.
結論:
- 開発された半合成法により,α-syn.にPTMを正確に導入することができる.
- この進歩は,α-synの生物学と疾患におけるPTMの役割を理解するために重要である.
- 健康と神経変性疾患におけるα-syn PTMに関する将来の研究を促進します.
さらに関連する動画
関連する概念動画
Phosphorylation
The addition or removal of phosphate groups from proteins is the most common chemical modification that regulates cellular processes. These modifications can affect the structure, activity, stability, and localization of proteins within cells as well as their interactions with other proteins.
During phosphorylation, protein kinases transfer the terminal phosphate group of ATP to specific amino acid side chains of substrate proteins. Serine, threonine, and tyrosine are the most commonly...
During phosphorylation, protein kinases transfer the terminal phosphate group of ATP to specific amino acid side chains of substrate proteins. Serine, threonine, and tyrosine are the most commonly...
Covalently Linked Protein Regulators
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein.
These groups modify specific amino acids in a protein.
Protein Modifications in the RER
Modification of secretory and transmembrane proteins entering the rough ER begins in the ER lumen. These modifications aid in protein folding and stabilize the acquired tertiary structure. Protein modifications in the rough ER co-occur at different stages of protein folding.
Broadly, these modifications can be categorized into four main categories — glycosylation, formation of disulfide bonds, assembly of protein subunits, and specific proteolytic cleavages like removal of signal sequences.
Broadly, these modifications can be categorized into four main categories — glycosylation, formation of disulfide bonds, assembly of protein subunits, and specific proteolytic cleavages like removal of signal sequences.
Protein Kinases and Phosphatases
Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...


